TRPM7 is abundantly present in reactive astrocytes at MS lesion sites, and boosts glial scar formation and restrains neuronal synaptic growth by elevating chondroitin sulfate proteoglycans (CSPGs) production [77]. Here, TRPM7 is linked to myeloid sarcoma.